CynergisTek Announces Northeast Health System Expands Relationship with Addition of Medical Device Security Services
18 November 2021 - 3:30PM
Business Wire
Northeast health system chooses CynergisTek to
assess the organization’s medical device security program and help
build out specific policies and procedures unique to securing
medical devices
CynergisTek (NYSE American: CTEK), a leading cybersecurity,
privacy, compliance, and IT audit firm helping organizations in
highly regulated industries navigate emerging security and privacy
issues, announces a six-figure expansion contract with a large
multi-site health system to conduct medical device security
assessment and program development services.
Network-connected medical devices are one of the biggest
cybersecurity challenges for healthcare organizations since they
can often be a potential unwelcome backdoor into their environment
and a risk to patient safety and privacy. On average there are
10-15 connected medical devices per bed, multiply that by the
number of beds in the U.S. and the threat of these devices
materializes quickly. “The problem is that with the proliferation
of Internet of Things (IoT), the speed at which new medical devices
are introduced into a Healthcare Delivery Organization’s (HDO)
network has increased. Both new and legacy devices being used today
have introduced vulnerabilities due to outdated or insecure
software, poor configurations, location, etc.,” said Mac McMillan,
CEO and President at CynergisTek.
CynergisTek’s medical device security team will work with the
health system to evaluate the effectiveness of their program for
providing ongoing risk management of connected devices and will
develop policies and procedures that are unique to medical devices
beginning with pre-procurement security reviews, identifying, and
prioritizing risk, and updating vulnerabilities with the
manufacturer. “Cybersecurity is complex and constantly evolving –
there are so many moving parts. With the increase in IoT and the
number of ransomware attacks on healthcare organizations, many are
bringing in the expertise to help review and improve upon medical
device security programs to ensure that they are doing their best
to protect patient safety and privacy,” said Dave Bailey, VP of
Security Services at CynergisTek.
“Working with our client is a sign of another great partnership,
and I would like to give credit to their team and the hospital’s
leadership for investing in and making security a priority for
their organization – many have not performed this important
analysis, but the tide is shifting as more HDOs are understanding
the importance of addressing this risk,” said Mac McMillan. He goes
onto say, “Working with CynergisTek’s team that combines both
cybersecurity and clinical engineering experts helps organizations
identify and address network-connected medical device security in a
holistic fashion. Compromise of these devices can lead to patient
harm or become the jumping off point for disrupting hospital
operations and patient care and lead to the losses in revenue in
the millions.”
About CynergisTek, Inc.
CynergisTek (www.cynergistek.com), is a top-ranked cybersecurity
consulting firm helping organizations in highly-regulated
industries, including those in healthcare, government, and finance
navigate emerging security and privacy issues. CynergisTek combines
intelligence, expertise, and a distinct methodology to validate a
company's security posture and ensure the team is rehearsed,
prepared, and resilient against threats. Since 2004, CynergisTek
has been dedicated to hiring and retaining experts who bring
real-life experience and hold advanced certifications to support
and educate the industry by contributing to relevant industry
associations. For more information, visit www.cynergistek.com or
follow us on Twitter or LinkedIn.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek, Inc. These forward-looking
statements are within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”) and Section 21E of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and can be identified by the use of forward-looking
terminology such as “believes,” “expects,” “anticipates,” “would,”
“could,” “intends,” “may,” “will,” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including but not limited to uncertainties relating
to product/services development; long and uncertain sales cycles;
the ability to obtain or maintain proprietary intellectual property
protection; future capital requirements; competition from other
providers; the ability of the Company’s vendors to continue
supplying the Company with supplies and services at comparable
terms and prices; the Company’s ability to successfully compete and
introduce enhancements and new features that achieve market
acceptance and that keep pace with technological developments; the
Company’s ability to maintain its brand and reputation and retain
or replace its significant customers; cybersecurity risks and risks
of damage and interruptions of information technology systems; the
Company’s ability to retain key members of management and
successfully integrate new executives; the Company’s ability to
complete acquisitions, strategic investments, entry into new lines
of business, divestitures, mergers or other transactions on
acceptable terms, or at all; potential risks and uncertainties
relating to the existing and ultimate impact of COVID-19, including
the geographic spread, the severity of the virus, the duration of
the COVID-19 outbreak, actions that may be taken by governmental
authorities to contain the COVID-19 outbreak or to treat its
impact, and the potential negative impacts of COVID-19 on the
global economy and financial markets, and other factors that may
cause actual results to be materially different from those
described herein as anticipated, believed, estimated or expected.
Certain of these risks and uncertainties are or will be described
in greater detail in the Company’s Form 10-K and Form 10-Q filings
with the Securities and Exchange Commission, which are available at
http://www.sec.gov. Given the risks and uncertainties, readers
should not place undue reliance on any forward-looking statement
and should recognize that the statements are predictions of future
results which may not occur as anticipated. Many of the risks
listed above have been, and may further be, exacerbated by the
COVID-19 pandemic, including its impact on the healthcare industry.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the risks and uncertainties described herein, as well as others not
now anticipated. CynergisTek is under no obligation (and expressly
disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211118005553/en/
CynergisTek Investor Relations Contact: CynergisTek, Inc.
Bryan Flynn (512) 402-8550 x8 InvestorRelations@cynergistek.com
CynergisTek Media Contact: Allison + Partners Jaime Tero
415-755-8639 jaime.tero@allisonpr.com
CynergisTek (AMEX:CTEK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
CynergisTek (AMEX:CTEK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024